132 related articles for article (PubMed ID: 32165229)
21. Bionanocomposite scaffolds based on chitosan-gelatin and nanodimensional bioactive glass particles: In vitro properties and in vivo bone regeneration.
Covarrubias C; Cádiz M; Maureira M; Celhay I; Cuadra F; von Marttens A
J Biomater Appl; 2018 Apr; 32(9):1155-1163. PubMed ID: 29451421
[TBL] [Abstract][Full Text] [Related]
22. Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Du X; Gao N; Song X
Drug Deliv; 2021 Dec; 28(1):252-260. PubMed ID: 33501870
[TBL] [Abstract][Full Text] [Related]
23. Nanofibrillated cellulose/cyclodextrin based 3D scaffolds loaded with raloxifene hydrochloride for bone regeneration.
Kamel R; El-Wakil NA; Abdelkhalek AA; Elkasabgy NA
Int J Biol Macromol; 2020 Aug; 156():704-716. PubMed ID: 32289405
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
Jia WT; Fu Q; Huang WH; Zhang CQ; Rahaman MN
Antimicrob Agents Chemother; 2015 Dec; 59(12):7571-80. PubMed ID: 26416858
[TBL] [Abstract][Full Text] [Related]
25. Investigating the mechanical, physiochemical and osteogenic properties in gelatin-chitosan-bioactive nanoceramic composite scaffolds for bone tissue regeneration: In vitro and in vivo.
Dasgupta S; Maji K; Nandi SK
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():713-728. PubMed ID: 30423758
[TBL] [Abstract][Full Text] [Related]
26. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Martel C; Picard S; Richard V; Bélanger A; Labrie C; Labrie F
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
[TBL] [Abstract][Full Text] [Related]
27. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
Varshosaz J; Minaiyan M; Dayyani L
Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
[TBL] [Abstract][Full Text] [Related]
28. Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability.
Tran TH; Ramasamy T; Cho HJ; Kim YI; Poudel BK; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2014 Jul; 14(7):4820-31. PubMed ID: 24757949
[TBL] [Abstract][Full Text] [Related]
29. Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase.
Liao J; Ren X; Yang B; Li H; Zhang Y; Yin Z
Drug Dev Ind Pharm; 2019 Jan; 45(1):88-95. PubMed ID: 30198790
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.
Tran TH; Poudel BK; Marasini N; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Feb; 443(1-2):50-7. PubMed ID: 23318367
[TBL] [Abstract][Full Text] [Related]
31. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
32. A potential antibacterial wound dressing of cefadroxil chitosan nanoparticles in situ gel: Fabrication, in vitro optimization and in vivo evaluation.
Basha M; AbouSamra MM; Awad GA; Mansy SS
Int J Pharm; 2018 Jun; 544(1):129-140. PubMed ID: 29655798
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of raloxifene hydrochloride-loaded subdermal implants using hot-melt extrusion technology.
Muhindo D; Ashour EA; Almutairi M; Repka MA
Int J Pharm; 2022 Jun; 622():121834. PubMed ID: 35597391
[TBL] [Abstract][Full Text] [Related]
34. Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles.
Couto DS; Hong Z; Mano JF
Acta Biomater; 2009 Jan; 5(1):115-23. PubMed ID: 18835230
[TBL] [Abstract][Full Text] [Related]
35. Enhanced bioavailability of raloxifene hydrochloride via dry suspensions prepared from drug/HP-β-cyclodextrin inclusion complexes.
Lu R; Liu S; Wang Q; Li X
Pharmazie; 2015 Dec; 70(12):791-7. PubMed ID: 26817276
[TBL] [Abstract][Full Text] [Related]
36. Preparation and in vitro/in vivo evaluation of cyclosporin A-loaded nanodecorated ocular implants for subconjunctival application.
Pehlivan SB; Yavuz B; Çalamak S; Ulubayram K; Kaffashi A; Vural İ; Çakmak HB; Durgun ME; Denkbaş EB; Ünlü N
J Pharm Sci; 2015 May; 104(5):1709-20. PubMed ID: 25716582
[TBL] [Abstract][Full Text] [Related]
37. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
[TBL] [Abstract][Full Text] [Related]
38. Osteoinductive fibrous scaffolds of biopolymer/mesoporous bioactive glass nanocarriers with excellent bioactivity and long-term delivery of osteogenic drug.
El-Fiqi A; Kim JH; Kim HW
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1140-52. PubMed ID: 25531645
[TBL] [Abstract][Full Text] [Related]
39. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
Javia A; Thakkar H
J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
[TBL] [Abstract][Full Text] [Related]
40. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
